Turn Therapeutics Inc. (TTRX) financial statements and ratios from SEC XBRL: revenue $29583.00 (TTM), net margin -10797.0%, revenue growth 861.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $29583.00 |
| Net Margin | -10797.0% |
| Revenue Growth (YoY) | 861.8% |
| EPS Growth (YoY) | 200.0% |
| Price / Book | 411.77 |
| Price / Sales | 4252.87 |
| Altman Z-Score | 18.46 (safe) |
| Sector P/E (Healthcare) | 21.7 |
TTRX overview · TTRX earnings · TTRX KPIs · TTRX investor relations · TTRX ownership · TTRX peers · TTRX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.